4 results
diagnosis management anemia aplastic apml cyp3a4 differentiation inducers inhibitors interactions mds myelodysplasia myelodysplastic pglycoprotein pharmacology syndromes table
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
) Cancer-treatment ... thereby leading ... metabolization leading ... inducers #inhibitors #Chemotherapy ... #Oncology #Hematology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
ecchymoses, mucosal bleeding ... Cytotoxic drugs/Chemotherapy ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis
Myelodysplastic Syndromes (MDS) What? Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
unusual bruising or bleeding ... are caused by bleeding ... ) • Intensive chemotherapy ... #diagnosis #hematology ... #oncology
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... diagnosis #management #hematology ... #oncology
No results found for "bleeding lellis pulmonary treatment radiology syndrome oncology hematology doac chemotherapy"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #bleeding #lellis #pulmonary #treatment #radiology #syndrome #oncology #hematology #doac #chemotherapy